Contraception for adolescents

Pediatric Annals

Volumn 42, Issue 2, 2013, Pages 21-25

  Yen, Sophia ^a   Martin, Susanne ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; ULIPRISTAL;

ABSTINENCE; ADOLESCENCE; ADOLESCENT PREGNANCY; ARTICLE; CONDOM; CONTRACEPTION; COPPER INTRAUTERINE DEVICE; COUNSELING; HUMAN; LEGAL ASPECT; REPRODUCTIVE HEALTH; RISK; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; VAGINA RING;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT HEALTH SERVICES; CONTRACEPTION; CONTRACEPTION, POSTCOITAL; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; CONTRACEPTIVES, POSTCOITAL; DIRECTIVE COUNSELING; HUMANS; INTRAUTERINE DEVICES; UNITED STATES;

EID: 84873948276     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20130128-08     Document Type: Article

References (17)

1. Singh S, Darroch JE. Adolescent pregnancy and childbearing: levels and trends in developed countries. Fam Plann Perspect. 2000;32(1):14-23.
2. Santelli JS, Lindberg LD, Finer LB, Singh S. Explaining recent declines in adolescent pregnancy in the United States: the contribution of abstinence and improved contraceptive use. Am J Public Health. 2007;97(1):150-156.
3. Jones RK, Purcell A, Singh S, Finer LB. Adolescents' reports of parental knowledge of adolescents' use of sexual health services and their reactions to mandated parental notification for prescription contraception. JAMA. 2005;293(3):340-348.
4. Youth Risk Behavior Surveillance - United States, 2011. MMWR. 2012;61(4).
5. von Hertzen H, Piaggio G. Levonorgestrel and mifepristone in emergency contraception. Steroids. 2003;68(10-13):1107-1113.
6. Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555-562.
7. Kaneshiro B, Aeby T. Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device. Int J Womens Health. 2010;2:211-220.
8. WHO. Medical Eligibility Criteria for Contraceptive Use. Fourth edition. Geneva, Switzerland: WHO Press; 2010.
9. Duffy K, Gold MA. Adolescents and emergency contraception: update 2011. Curr Opin Obstet Gynecol. 2011;23(5):328-333.
10. Lidegaard O, Nielsen LH, Skovlund CW, Lokkegaard E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ. 2012;344:e2990.
11. Gladwell M. Annals of Medicine. "John Rock's error.". The New Yorker. March 13, 2000:52.
12. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med. 2005;159(2):139-144.
13. Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar MS, eds. Contraceptive Technology. 20th ed. New York, NY: Ardent Media; 2011.
14. Curtis KM, Jamieson DJ, Peterson HB, Marchbanks PA. Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States. Contraception. 2010;82(1):3-9.
15. Committee on Adolescent Healthcare Long Acting-Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2012;120(4):983-988.
16. Yen S, Saah T, Hillard PJ. IUDs and adolescents--an under-utilized opportunity for pregnancy prevention. J Pediatr Adolesc Gynecol. 2010;23(3):123-128.
17. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception. 2002;65(2):129-132.